High STX1A expression in luminal B and HER2-enriched tumors correlated with even lower overall survival (Figure 6D–6E) and can therefore be considered an indicator of poor prognosis for this breast cancer subtypes. The gene discussed is ERBB2; the disease is breast carcinoma.